Tilburg University
Tilburg, Nood-Brabant, 5037 AB, Netherlands
NCT Number: NCT02303938
The objective of this pilot randomized controlled trial (RCT) is to assess the feasibility and to determine the effect size of an exercise program in improving objective cognitive functioning.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Tilburg, Nood-Brabant, 5037 AB, Netherlands
Clinical stable patients with 1) low grade glioma (LGG) or 2) anaplastic glioma under age 70 will undergo a home-based exercise program (intervention) or will be assigned to the active controle group. Patients in the intervention group will undergo a 6-month home-based exercise intervention. An individual exercise prescription will be based on the patients' level of aerobic fitness (VO2peak) as measured with cardiopulmonary testing (CPET; on a cycle ergometer with ECG and gas exchange measurement) at baseline. Patients will exercise (e.g., running, biking, swimming) three times per week for 6 months. Session duration will vary between 20 minutes and 45 minutes. Patients in the active control group will be advised to walk regularly based on brochures from 30minutenbewegen.nl.
All primary and secondary outcomes will be assessed at baseline (T0; prior to randomization), and at completion of the 6-month exercise intervention (T1), and at a similar time-point for patients in the active control group. These will include indicators of feasibility (accrual, adherence, compliance and attrition), subjective and objective physical fitness measures, neuropsychological performance scores, and self-reported cognitive symptoms and mental wellbeing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For assessment purposes, study participants will need to have basic fluency in the Dutch language.
Patients in the intervention group will undergo a 6-month home-based exercise intervention. Patients will exercise (e.g., running, biking, swimming) three times per week for 6 months. Session duration will vary between 20 minutes and 45 minutes.
Time frame: 6 months after the initial assessment
neuropsychological test battery will be administered to patients at baseline and immediately after the intervention at 6 months
Time frame: 6 months after the initial assessment
Intervention-related improvement of physical fitness will be assessed with a maximum cardiopulmonary exercise test (CPET). VO2 and of course adverse events are recorded immediately after the intervention ended at 6 months
Time frame: 6 months after the initial assessment
mood, sleep, fatique, quality of life, and depression are measured with self-reported questionaires at baseline and after intervention at 6 months such as Profile of Mood States (POMS) brief, Multidimensional Fatigue Inventory (MFI), Pittsburgh Sleep Inventory, MOS SF-36 Item Health Survey SF-36, and Brain-cancer specific HRQL questionnaire (QLQ-BN20)
Time frame: 6 months after the initial assessment
Subjective cognition is measured with self-reported questionaire at baseline and after intervention at 6 months
Time frame: 6 months after the initial assessment
Mental well-being is measured with specific questionaire at baseline and after intervention at 6 months
Tilburg University
Other
A Pilot Randomized Controlled Trial on the Feasibility and Efficacy of an Exercise Intervention to Improve Cognitive Functioning in Patients With Glioma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07110246
BRAF V600 Mutation, Low Grade Glioma of Brain
Birmingham, Alabama, United States
View Trial DetailsNCT04859725
Low Grade Glioma of Brain
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT05555550
Glioma, Glioma Intracranial
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07547163
Glioma, Glioma of Brain
Milan, Italy
View Trial Details